These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12669466)

  • 1. Improving DNA vaccine potency via modification of professional antigen presenting cells.
    Hung CF; Wu TC
    Curr Opin Mol Ther; 2003 Feb; 5(1):20-4. PubMed ID: 12669466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
    Hung CF; Yang M; Wu TC
    Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccines for cancer.
    Boyd D; Hung CF; Wu TC
    IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of priming cytotoxic T cell response and strategy for enhancing DNA vaccine potency in DNA immunization].
    Deng X; Cai M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):175-9. PubMed ID: 12744193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccines--challenges in delivery.
    Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
    Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccination: antigen presentation and the induction of immunity.
    Shedlock DJ; Weiner DB
    J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The processing of antigens delivered as DNA vaccines.
    Howarth M; Elliott T
    Immunol Rev; 2004 Jun; 199():27-39. PubMed ID: 15233724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New tools for antigen delivery to the MHC class I pathway.
    Morón G; Dadaglio G; Leclerc C
    Trends Immunol; 2004 Feb; 25(2):92-7. PubMed ID: 15102368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming of CTL responses by DNA vaccines: direct transfection of antigen presenting cells versus cross-priming.
    Ulmer JB; Otten GR
    Dev Biol (Basel); 2000; 104():9-14. PubMed ID: 11713829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virosomes for antigen and DNA delivery.
    Daemen T; de Mare A; Bungener L; de Jonge J; Huckriede A; Wilschut J
    Adv Drug Deliv Rev; 2005 Jan; 57(3):451-63. PubMed ID: 15560951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
    Fredriksen AB; Sandlie I; Bogen B
    Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully mobilizing host defense: building better vaccines.
    Raychaudhuri S; Rock KL
    Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naked antigen-presenting molecules on dendritic cells.
    Davoust J; Banchereau J
    Nat Cell Biol; 2000 Mar; 2(3):E46-8. PubMed ID: 10707098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.
    Tsen SW; Paik AH; Hung CF; Wu TC
    Expert Rev Vaccines; 2007 Apr; 6(2):227-39. PubMed ID: 17408372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responses.
    McKay PF; Barouch DH; Santra S; Sumida SM; Jackson SS; Gorgone DA; Lifton MA; Letvin NL
    Eur J Immunol; 2004 Apr; 34(4):1011-20. PubMed ID: 15048711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting plasmid-encoded proteins to the antigen presentation pathways.
    Leifert JA; Rodriguez-Carreno MP; Rodriguez F; Whitton JL
    Immunol Rev; 2004 Jun; 199():40-53. PubMed ID: 15233725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in antigen processing and presentation.
    Jensen PE
    Nat Immunol; 2007 Oct; 8(10):1041-8. PubMed ID: 17878914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cross-priming pathway: a portrait of an intricate immune system.
    Basta S; Alatery A
    Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation to naive CD4 T cells in the lymph node.
    Itano AA; Jenkins MK
    Nat Immunol; 2003 Aug; 4(8):733-9. PubMed ID: 12888794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.